市場調査レポート - 107934

米国の末梢血管疾患管理のためのインターベンション製品および技術市場

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

発行 Medtech Insight
出版日 ページ情報 英文 240 Pages
価格
米国の末梢血管疾患管理のためのインターベンション製品および技術市場 U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies
出版日: 2009年09月30日 ページ情報: 英文 240 Pages
概要

末梢血管疾患管理のための診断、治療介入数は2013年まで年率3.1%で増加し、2013年には350万件近くになると予測されています。これに伴い関連製品の売上も2013年に18億3,000万米ドルに達すると見られています。

当レポートは、米国の末梢血管疾患の治療と診断に用いられるインターベンションデバイスについて、市場の現状と競合企業、サプライヤーにとっての機会などを検証し、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 末梢血管疾患

  • 循環系の生体構造と生理学
  • 末梢血管疾患の種類
    • 末梢動脈疾患
    • 動脈瘤
    • 深部静脈血栓症、肺塞栓
    • 慢性静脈不全

第2章 末梢血管疾患診断のためのインターベンション製品市場

  • 低侵襲性診断
    • 足関節上腕血圧比
    • 運動負荷試験
    • 画像方法 他
  • インターベンション診断市場分析
    • 血管造影
    • 血管内超音波法

第3章 末梢血管疾患治療のためのインターベンション製品市場

  • 低侵襲性治療
    • ライフスタイルの変化
    • 薬剤療法
  • 外科的/内視鏡的治療
    • 大腿膝窩動脈バイパス
    • 血栓内膜摘除術
    • 慢性静脈不全、静脈性潰瘍治療
  • インターベンション治療市場分析
    • 経皮経管的血管形成
    • カテーテル血栓溶解
    • 慢性完全閉塞 他

第4章 企業プロファイル

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Arrow International/Teleflex, Inc.
  • Bacchus Vascular/Covidien LTD
  • C.R. Bard, Inc.
  • BioSphere Medical, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cardiovascular Systems, Inc.
  • Cook Group
  • Cordis Corporation/Johnson & Johnson
  • ev3, Inc.
  • MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
  • Medtronic, Inc.
  • Spectranetics Corporation
  • Terumo Interventional Systems/Terumo Corporation
  • Volcano Corporation

付録:企業リスト

目次

Abstract

Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; other types of PVD include aneurysm, chronic venous insufficiency, deep-vein thrombosis, and pulmonary embolism.

In 2008, approximately 3.0 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.18 billion in corresponding product sales. The number of diagnostic and therapeutic interventions for PVD management is expected to increase at a compound annual rate of 3.1% during the forecast period covered by this report, reaching nearly 3.5 million in the year 2013. Sales of products to perform these interventional procedures are projected to increase at a compound annual rate of 9.2% during the forecast period covered by this report, reaching an estimated $1.83 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional devices for the diagnosis and treatment of PVD in the U.S.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; chronic total occlusion crossing systems; drug-eluting balloon systems; endovascular cryotherapy products; endovascular embolization products; intravascular ultrasound systems; mechanical atherectomy systems; mechanical and pharmacomechanical thrombectomy products; noninvasive peripheral vascular disease treatments; peripheral transluminal angioplasty devices; surgical/endoscopic peripheral vascular disease treatments; and vena cava filters.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

Table of Contents

EXECUTIVE SUMMARY

  • i. Interventional Peripheral Vascular Disease Diagnostic Products Market
    • a. Angiography
    • b. Intravascular Ultrasound
  • ii. Interventional Peripheral Vascular Disease Treatment Products Market
    • a. Percutaneous Transluminal Angioplasty
    • b. Catheter-Directed Thrombolysis
    • c. Chronic Total Occlusion Crossing
    • d. Mechanical Atherectomy
    • e. Endovascular Embolization
    • f. Thrombectomy
    • g. Vena Cava Filter Placement
    • h. Endovascular Cryotherapy
  • i. Drug-Eluting Balloon Angioplasty
  • iii. Methodology
  • Exhibit ES-1: Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2008-2013
  • Exhibit ES-2: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2008-2013
  • Exhibit ES-3: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, by Segment 2008-2013
  • Exhibit ES-4: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013
  • Exhibit ES-5: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
  • Exhibit ES-6: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013
  • Exhibit ES-7: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013
  • Exhibit ES-8: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
  • Exhibit ES-9: Mechanical Atherectomy Systems, Market Forecast, 2008-2013
  • Exhibit ES-10: Endovascular Embolization Products, Market Forecast, 2008-2013
  • Exhibit ES-11: Thrombectomy Systems,Market Forecast, 2008-2013
  • Exhibit ES-12: Vena Cava Filter Systems, Market Forecast, 2008-2013
  • Exhibit ES-13: Endovascular Cryotherapy Systems, Market Forecast, 2008-2013
  • Exhibit ES-14: Drug Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

1. PERIPHERAL VASCULAR DISEASE OVERVIEW

  • 1.1 Anatomy and Physiology of the Circulatory System
  • 1.2 Types of Peripheral Vascular Disease
    • 1.2.1 Peripheral Artery Disease
      • 1.2.1.1 Etiology
      • 1.2.1.2 Epidemiology
    • 1.2.2 Aneurysm
      • 1.2.2.1 Etiology
      • 1.2.2.2 Epidemiology
    • 1.2.3 Deep Vein Thrombosis and Pulmonary Embolism
      • 1.2.3.1 Etiology
      • 1.2.3.2 Epidemiology
    • 1.2.4 Chronic Venous Insufficiency
      • 1.2.4.1 Etiology
      • 1.2.4.2 Epidemiology
  • Exhibit 1-1: 2009, Peripheral Artery Disease, Facts and Figures
  • Exhibit 1-2: 2009, Aortic Aneurysm, Facts and Figures
  • Exhibit 1-3: 2009, Deep Vein Thrombosis, Facts and Figures
  • Exhibit 1-4: Classification of Chronic Venous Insufficiency
  • Exhibit 1-5: 2009, Chronic Venous Insufficiency, Facts and Figures

2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET

  • 2.1 Noninvasive Peripheral Vascular Disease Diagnostics
    • 2.1.1 Ankle/Brachial Index
    • 2.1.2 Exercise Tolerance Testing
    • 2.1.3 Imaging Methods
      • 2.1.3.1 Computed Tomography
      • 2.1.3.2 Magnetic Resonance Imaging
      • 2.1.3.3 Thermography
      • 2.1.3.4 Ultrasound Imaging
    • 2.1.4 Photoplethysmography and Air Plethysmography
  • 2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis
    • 2.2.1 Angiography
      • 2.2.1.1 Types
        • 2.2.1.1.1 Peripheral Arterial Angiography
        • 2.2.1.1.2 Peripheral Venous Angiography
      • 2.2.1.2 Procedures/Technologies
      • 2.2.1.3 Products
      • 2.2.1.4 Market Forecast
      • 2.2.1.5 Competitors
    • 2.2.2 Intravascular Ultrasound
      • 2.2.2.1 Procedures/Technologies
      • 2.2.2.2 Products
      • 2.2.2.3 Market Forecast
      • 2.2.2.4 Competitors
  • Exhibit 2-1: Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2008-2013
  • Exhibit 2-2: Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2008-2013
  • Exhibit 2-3: Peripheral Angiography, Procedure Volumes Forecast, 2008-2013
  • Exhibit 2-4: 2009, Selected Angiography Catheters
  • Exhibit 2-5: 2009, Selected Diagnostic Guidewires
  • Exhibit 2-6: 2009, Selected Introducers/Sheaths
  • Exhibit 2-7: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013
  • Exhibit 2-8: 2008, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier
  • Exhibit 2-9: Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013
  • Exhibit 2-10: 2009, Selected Intravascular Ultrasound Catheters
  • Exhibit 2-11: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013
  • Exhibit 2-12: 2008, Intravascular Ultrasound Catheters Market, Share by Supplier

3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET

  • 3.1 Noninvasive Peripheral Vascular Disease Treatments
    • 3.1.1 Lifestyle Changes
      • 3.1.1.1 Exercise Therapy
      • 3.1.1.2 Diet Modification
      • 3.1.1.3 Smoking Cessation
      • 3.1.1.4 Compression Therapy
    • 3.1.2 Drug Therapy
      • 3.1.2.1 Anticoagulants and Antiplatelet Drugs
      • 3.1.2.2 Dyslipidemia Management Drugs
  • 3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments
    • 3.2.1 Femoropopliteal Bypass Graft Surgery
    • 3.2.2 Thromboendarterectomy
    • 3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments
      • 3.2.3.1 Deep Vein Reconstruction
      • 3.2.3.2 Open Subfascial Perforator Surgery
      • 3.2.3.3 Skin Grafting
      • 3.2.3.4 Subfascial Endoscopic Perforator Surgery
      • 3.2.3.5 Superficial Vein Stripping
  • 3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis
    • 3.3.1 Percutaneous Transluminal Angioplasty
      • 3.3.1.1 Procedures/Technologies
      • 3.3.1.2 Products
        • 3.3.1.2.1 Balloon Catheters
        • 3.3.1.2.2 Guiding Catheters
        • 3.3.1.2.3 Guidewires
        • 3.3.1.2.4 Introducers/Sheaths
        • 3.3.1.2.5 Accessories
      • 3.3.1.3 Market Forecast
      • 3.3.1.4 Competitors
    • 3.3.2 Catheter-Directed Thrombolysis
      • 3.3.2.1 Procedures/Technologies
      • 3.3.2.2 Products
      • 3.3.2.3 Market Forecast
      • 3.3.2.4 Competitors
    • 3.3.3 Chronic Total Occlusion Crossing
      • 3.3.3.1 Procedures/Technologies
      • 3.3.3.2 Products
      • 3.3.3.3 Market Forecast
      • 3.3.3.4 Competitors
    • 3.3.4 Mechanical Atherectomy
      • 3.3.4.1 Procedures/Technologies
      • 3.3.4.2 Products
      • 3.3.4.3 Market Forecast
      • 3.3.4.4 Competitors
    • 3.3.5 Endovascular Embolization
      • 3.3.5.1 Procedures/Technologies
      • 3.3.5.2 Products
      • 3.3.5.3 Market Forecast
      • 3.3.5.4 Competitors
    • 3.3.6 Thrombectomy
      • 3.3.6.1 Procedures/Technologies
      • 3.3.6.2 Products
      • 3.3.6.3 Market Forecast
      • 3.3.6.4 Competitors
    • 3.3.7 Vena Cava Filter Placement
      • 3.3.7.1 Procedures/Technologies
      • 3.3.7.2 Products
      • 3.3.7.3 Market Forecast
      • 3.3.7.4 Competitors
    • 3.3.8 Other/Emerging
      • 3.3.8.1 Endovascular Cryotherapy
        • 3.3.8.1.1 Procedures/Technologies
        • 3.3.8.1.2 Products
        • 3.3.8.1.3 Market Forecast
      • 3.3.8.2 Drug-Eluting Balloon Angioplasty
        • 3.3.8.2.1 Procedures/Technologies
        • 3.3.8.2.2 Products
        • 3.3.8.2.3 Market Forecast
  • Exhibit 3-1: Interventional Peripheral Vascular Disease Treatment, Combined Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-2: Interventional Peripheral Vascular Disease Treatment Products, Combined Market Forecast, 2008-2013
  • Exhibit 3-3: Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-4: 2009, Selected Percutaneous Transluminal Angioplasty Balloon Catheters
  • Exhibit 3-5: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013
  • Exhibit 3-6: 2008, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier
  • Exhibit 3-7: Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-8: 2009, Selected Catheter-Directed Thrombolysis Systems
  • Exhibit 3-9: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013
  • Exhibit 3-10: 2008, Catheter-Directed Thrombolysis Systems Market, Share by Supplier
  • Exhibit 3-11: Powered Chronic Total Occlusion Crossing, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-12: 2009, Selected Powered Chronic Total Occlusion Crossing Systems
  • Exhibit 3-13: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013
  • Exhibit 3-14: 2008, Powered Chronic Total Occlusion Crossing Systems Market, Share by Supplier
  • Exhibit 3-15: Mechanical Atherectomy, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-16: 2009, Selected Mechanical Atherectomy Systems
  • Exhibit 3-17: Mechanical Atherectomy Systems, Market Forecast, 2008-2013
  • Exhibit 3-18: 2008, Mechanical Atherectomy Systems Market, Share by Supplier
  • Exhibit 3-19: Endovascular Embolization, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-20: 2009, Selected Endovascular Embolization Products
  • Exhibit 3-21: Endovascular Embolization Products, Market Forecast, 2008-2013
  • Exhibit 3-22: 2008, Endovascular Embolization Products Market, Share by Supplier
  • Exhibit 3-23: Thrombectomy, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-24: 2009, Selected Thrombectomy Systems
  • Exhibit 3-25: Thrombectomy Systems, Market Forecast, 2008-2013
  • Exhibit 3-26: 2008, Thrombectomy Systems Market, Share by Supplier
  • Exhibit 3-27: Vena Cava Filter Placement, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-28: 2009, Selected Vena Cava Filter Systems
  • Exhibit 3-29: Vena Cava Filter Systems, Market Forecast, 2008-2013
  • Exhibit 3-30: 2008, Vena Cava Filter Systems Market, Share by Supplier
  • Exhibit 3-31: Endovascular Cryotherapy, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-32: Endovascular Cryotherapy Systems,Market Forecast, 2008-2013
  • Exhibit 3-33: Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013
  • Exhibit 3-34: Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013

4. COMPANY PROFILES

  • 4.1 Abbott Laboratories
  • 4.2 AngioDynamics, Inc.
  • 4.3 Arrow International/Teleflex, Inc.
  • 4.4 Bacchus Vascular/Covidien LTD
  • 4.5 C.R. Bard, Inc.
  • 4.6 BioSphere Medical, Inc.
  • 4.7 Boston Scientific Corporation
  • 4.8 B. Braun Melsungen AG
  • 4.9 Cardiovascular Systems, Inc.
  • 4.10 Cook Group
  • 4.11 Cordis Corporation/Johnson & Johnson
  • 4.12 ev3, Inc.
  • 4.13 MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
  • 4.14 Medtronic, Inc.
  • 4.15 Spectranetics Corporation
  • 4.16 Terumo Interventional Systems/Terumo Corporation
  • 4.17 Volcano Corporation

APPENDIX: COMPANY LISTING

Back to Top